Zeria Pharmaceutical’s Swiss subsidiary Tillotts Pharma acquired Germany-based pharmaceutical manufacturer Haupt Pharma Wulfling. Haupt Pharma Wulfling is a subsidiary of Aenova Holding and operates a manufacturing facility in Germany.
Zeria Pharmaceutical’s Swiss subsidiary Tillotts Pharma acquired Haupt Pharma Wulfling, a subsidiary of Germany’s Aenova Holding engaged in pharmaceutical manufacturing. The target is a pharmaceutical manufacturing company with operations in Germany, and the acquisition is expected to strengthen Tillotts’ business operations.
Haupt Pharma Wulfling, the acquisition target, is a company belonging to Aenova Holding, and it has been reported that the transaction will integrate it into Tillotts’ business portfolio.